News

Press Release | Aug 06, 2019

Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), today announced its second quarter 2019 operational and financial results. For more information, please refer to the Management’s Discussion & Analysis of Financial Condition and Results of Operations (“MD&A”) and the unaudited condensed interim consolidated financial statements of the Company for the three and six months

Press Release | Jun 26, 2019

Innovative Health, the leading single-use cardiology medical device reprocessing company, today announced it has received FDA clearance for reprocessing the market-leading PENTARAY® Nav eco High-Density mapping catheter (hereinafter PentaRay), a development that represents both a technological and healthcare cost reduction milestone. The PentaRay is a key medical device in Atrial Fibrillation (AF) procedures, one of

Press Release | Jun 17, 2019

MedTech Innovator, the premier nonprofit accelerator in the medical technology industry, today announced the 50 companies selected to participate in the organization’s flagship four-month program, featuring leading-edge device, diagnostic, and digital health technologies from around the world. These best-in-class startups will receive unparalleled visibility and access to leading manufacturers, providers, investors, and other industry stakeholders.

Press Release | Jun 11, 2019

Colorescience®, leading dermatologist-recommended skincare and cosmetics company, is proud to announce that the United States Patent and Trademark Office has issued a patent covering formulations for treating, protecting and repairing skin around the eye area. These patents support Colorescience’s multifaceted formulation and product delivery method of Total Eye® Concentrate and Total Eye® 3-in-1 Renewal Therapy

News | Jun 06, 2019

Ristela, a plant-based product aimed at menopausal women that promises to increase sexual pleasure, was introduced on the women’s wellness website Bonafide a few weeks ago. Bonafide said that sales of Ristela in its first 10 days surpassed expectations for three months, and another menopause-focused product is planned for early next year.

Pages 1 2 3 4 5 11